Agoracom Blog Home

Posts Tagged ‘smallcap stocks’

CLIENT FEATURE: Innocan Pharma $INNO.ca Developing The Pharmaceutical Guided Missile To Defeat #Coronavirus Lung Infections $WEED.ca $CL.ca $HEXO.ca $RWB.ca

Posted by AGORACOM-JC at 5:36 PM on Friday, September 25th, 2020
Innocan-Blog

(INNO:CSE)

InnoCan Pharma Is A Pharmaceutical Company That Specializes In The Development Of New Drug Platforms Which Combine Unique Properties of Cannabinoids

WHY INNOCAN?

InnoCan has 3 fully operating divisions to address the market for Cannabis products.  As a Cannabis investor, why limit yourself to a Company with just one specialty, when InnoCan offers you exposure to both the exploding world of cannabis pharma, as well as, a portfolio of patent-pending and launch ready consumer health products.

PHARMACEUTICAL – THE GUIDED MISSILE

  • Revolutionary Technology Targeting Lungs Infected  With Coronavirus or other viral infections 
    • Done By Combining CBD with Stem Cell Particles (Exosomes)
    • Research & Licensing Agreement with Tel Aviv University
  • Developing CLX, The ICBM Ballistic Missile Of Coronavirus Lung Infections
  • Separate breakthrough delivery and control release technology that enables the injection of CBD.

CONSUMER RETAIL – DERMA COSMETICS 

Completed Successful Cosmetic Clinical Studies Demonstrating the Efficacy of Its SHIR(TM) CBD Premium Facial Serum on Skin Hydration

  • A Premium Derma Cosmetics Brand
  • Containing Highly Concentrated Ingredients Formulated with CBD
  • Manufacturing & Supply Agreements – Europe and United States
  • Manufacturing Has Commenced For 9 Products As Of Q2 2020
  • Distribution Agreements – United Kingdom and Ireland

OVER THE COUNTER (OTC) PRODUCTS FOR PAIN RELIEF

  • Patent-Pending CBD Pain Relief Brand
  • Versions Include Spray, Roll-On and Cream
  • Relief & Go Spray – First Product Being Manufactured
    • FDA Technical Validation
    • FDA Approval To Commence Marketing In The United States
  •   Manufacturing Commencement
    • New Jersey (United States Market)
    • Portugal (Asia and Europe Markets)
  • Sales Commenced In H2 2020 during September

SEEING IS BELIEVING

FULL DISCLOSURE: Innocan Pharma is an advertising client of AGORA Internet Relations Corp.

VIDEO: Innocan $INNO.ca Completes Successful Cosmetic Clinical Studies Demonstrating the Efficacy of Its SHIR(TM) #CBD Premium Facial Serum on Skin Hydration $WEED.ca $CL.ca $HEXO.ca $RWB.ca

Posted by AGORACOM-JC at 12:15 PM on Wednesday, September 16th, 2020
Innocan-Blog

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) has completed a cosmetic clinical study examining the impact of its SHIR ™ Premium CBD Facial Serum containing 300 mg of cannabidiol (“CBD“) on skin hydration.

  • Study was conducted by an independent research laboratory: INOVAPOTEK, Pharmaceutical Research and Development in Portugal”.
  • The study aimed to assess the hydrating efficacy of the Serum in vivo, by measuring the skin capacitance for a period of 2, 4, 8 and 24 hours after the CBD Serum application on the skin.
  • The results demonstrated that there were significant hydration increases for each period.
  • The Serum was well tolerated with no uncomfortable symptoms or feelings reported by the subjects of the study.

In addition, the research laboratory completed a clinical controlled study for the evaluation of the acute cutaneous irritation potential of cosmetic products. All of the SHIR™ Derma Cosmetic products tested to date have demonstrated to be non-irritating under the test conditions.

Read Full Release

CEO SPOTLIGHT: Iris Bincovich, CEO of Innocan Pharma $INNO.ca $WEED.ca $CL.ca $HEXO.ca $RWB.ca

Posted by AGORACOM-JC at 4:52 PM on Tuesday, September 15th, 2020
Innocan-Blog

Hub On AGORACOM / Corporate Profile

My Search for the Healthiest Baby Formula – SPONSOR: Else Nutrition $BABY.ca $MAT $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 6:12 PM on Thursday, May 7th, 2020

SPONSOR: Else Nutrition Holdings Inc. (TSX-V: BABY)The award winning, plant-based nutrition company for small cap investors. The company has a $10,000,000 cash balance for US product launch In Q2 2020 with International agreements in Q3. Learn More

http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png

My Search for the Healthiest Baby Formula

by Robin Barrie Kaiden, MS, RD, CDN

Robin Barrie Kaiden, MS, RD, CDN is renowned for helping people of all ages embrace a healthier lifestyle through nutrition and fitness counseling.  As a Licensed Registered Dietitian and Personal Trainer, her smart and sensible approach to pediatrics, weight loss, sports nutrition, allergies, cardiovascular health, pre/post natal, and other areas of clinical and lifestyle nutrition has resonated with hundreds of people across the United States. Robin received her B.S. and M.S. degrees in Nutrition and Exercise Science from Cornell and Columbia Universities.

A Personal Note from this Pediatric Registered Dietitian and Mom

When I began working as a Registered Dietitian in Pediatric Nutrition over 15 years ago, we, of course, were taught, and shared with patients, that breast milk was the best, healthiest option for feeding babies.  When that wasn’t possible, sufficient, or babies were being weaned, I knew that there were a variety of infant and toddler formulas available. We could recommend:

  1. Pre-term infant formula:  higher calories and minerals for infants born early
  2. Standard term infant formula:  intact milk protein
  3. Gentle/sensitive formulas: whey protein in milk partially broken down
  4. Soy-based formulas:  for those with milk intolerance, noting that over 50% of infants who don’t tolerate dairy, also do not tolerate soy protein
  5. Hydrolyzed formulas:  proteins are mostly, but not completely broken down
  6. Elemental formulas:  proteins completely broken down for severe milk allergies

At this point in my career, I did not study the ingredients of each, but rather selected the best option available to best aid in tolerance, intake and growth for the child.  There always seemed to be one that worked well…..at least well enough. The biggest problem with the hydrolyzed and elemental formulas was that they smelled and tasted terrible, and babies often refused to drink them.

Over 8 years ago, when I was pregnant with my first baby, I began to examine the healthiest baby formula options more in depth.   I discovered that not much had changed in this industry, except that there were a couple of organic options. After discussing with a colleague, I decided on a formula.  When my son was less than a week old, this product was recalled due to high arsenic levels. Plus, it seemed to upset his stomach. When my baby nurse suggested a non-organic, but “gentle” formula, I (reluctantly) agreed.  I disliked that it had corn syrup (processed inflammatory sugar) as one of the main ingredients, but I was a new mom, overwhelmed, and figured she had so much experience and knew what she was talking about. Plus, my pediatrician agreed as well.  A few weeks later, I just went back to the only other organic option on the market, and my son seemed to tolerate it well enough. It was the best I could find at that time. 

When it came time to find the healthiest baby formula for my second child, almost 2.5 years later, I become aware that there were some European products that had better ingredients.  However, it was pretty difficult and expensive to get these in the U.S. back then. I took comfort in the fact that my baby would be able to get great nutrition in the form of real food within about 4-5 months, and wean off formula totally at 1 year.  But all I could think was that I would love to create a new healthy baby formula myself. Why hadn’t someone come up with a better alternative yet? Aren’t the infant and toddler stages the most important as they are developing and growing so rapidly? Why wouldn’t everyone want offer the best possible nutrients to this group, if/when/after breast milk was not an option.

My children are now in elementary school and the infant/toddler formula industry is still, in my opinion extremely limited.  I was thrilled to hear about Else Nutrition, and flattered to consult on their timely products. Formulation of plant-based products is way overdue.   In the wake of a huge movement towards plant-based and plant-forward diets, due to increased research and interest, Else is a wonderful product to support infant and toddler Nutrition.  Read on to learn about all of its positive attributes.

Benefits of Else Plant-Based Formula Alternative

Choose Else Nutrition because it is:

  1. Organic:  This means that the USDA (United States Department of Agriculture) has determined that the ingredients in this healthy baby formula are free of genetically modified organisms (GMOs), fungicides, herbicides, and pesticides.   Organic practices result in enhanced soil and water quality and, in general, more overall sustainable farming (1).  Translation:  Organic foods are beneficial for our environment.  Research has shown that organic produce is more nutritious:  It has higher levels of antioxidants and lower levels of toxic metals (such as Cadmium).   Increased exposure to pesticides has been shown to increase risk for ADHD, Parkinson’s disease, diabetes, and some cancers (2).  The effects of chemicals used in conventional farming may be more detrimental to the small developing brains and bodies of babies/children than to those of adults. 
  2.  Glyphosate-free:  Yes, the USDA Organic Label is important, however, it may not be enough today.  It ensures that crops are GMO-free, but this doesn’t mean a product is 100% free of pesticides.   Glyphosate is an herbicide (pesticide) that is carcinogenic (can cause cancer). Final organic food products are often NOT tested.  The USDA does not check for glyphosate residue. The buckwheat and almond sources in Else formulas are glyphosate-free.
  3. Made from clean ingredients:  Else formulas are simple and pure.  Almonds, buckwheat, and tapioca make up about 92% of the product.  The ingredient list is short and easy to understand. There are no added unhealthy oils, inflammatory sugar/corn syrups, artificial sweeteners, or gums/stabilizers/fillers than can upset small bellies.   For moms looking to supplement breast milk or wean their children after 1 year of age, it may seem that there are many dairy-free milk substitutes and products on the market today; however, none are quite right for little developing brains and bodies.  They are not nearly as nutritionally dense as breast milk (or full-fat dairy milk). They may be low-fat, low in protein, and other nutrients, and often contain added sugars and fillers as mentioned above. They are simply NOT appropriate, and in fact, unhealthy as a foundation for a toddler’s diet.  This is especially true for vegans and/or those who truly cannot tolerate dairy protein.
  4. Pleasantly mild in flavor:  When babies are weaned off breast milk and/or need a supplement or substitute for human or cow’s milk, they are more likely to accept a drink/formula that tastes great (they are indeed little humans).  Other formulas may not be as mild.  In fact, the hydrolyzed/elemental formulas have a reputation of smelling bad and tasting worse.  Such formulas may be indicated for little ones with dairy allergies and intolerances, and digested well; however, if the child will not drink due to the smell/taste, this can be an issue.  
  5. Vegan/Plant-based:  In case you haven’t noticed, there has been a huge buzz surrounding “plant-based” and “plant-forward” nutrition.  This is not new news to us health professionals. We have always known that a variety of fruits, vegetables, whole grains, legumes, fiber, and healthy fats were integral for good health.  The research is finally catching up. We now know that our microbiome (the collection of microorganisms-bacteria, fungi, viruses-that live in/on the human body) can benefit our health, especially immunity, aging, digestion, metabolism, mood and mental health.   We can best benefit our microbiome by consuming a diet rich in a variety of plant-based foods. Why not start our little ones on such a diet with a plant-based formula?! Research shows that children on a predominantly plant-based diet have increased microbial biodiversity and richness (3).  
  6. Dairy-Free and Soy-free:  Infants and toddlers with food allergies, intolerances, and/or sensitivities simply cannot tolerate many formulas on the market today.  The incidence of food allergies is on the rise in children and adults. According to the Mayo Clinic: “Food allergy is an immune system reaction that occurs soon after eating a certain food. Even a tiny amount of the allergy-causing food can trigger signs and symptoms such as digestive problems, hives or swollen airways. In some people, a food allergy can cause severe symptoms or even a life-threatening reaction known as anaphylaxis.”(4)  Cow’s milk is the most allergenic food for in children in the U.S. (followed by peanuts, eggs and soy).  Most of the formulas on the market are based on cow’s milk.  

Else’s products can be tolerated by children with dairy and soy allergies and sensitivities.  Anaphylaxis due to almond or buckwheat allergy is very rare (<1% and 1% of anaphylaxis cases in children respectively) with numbers well below egg, wheat, fish, goat/sheep’s milk, lentils, cashew, and peanut.

Also, just as an update and reminder about almonds:  recent research demonstrates that delaying introduction of potential allergenic foods (wheat, dairy, eggs, fish and nuts) may actually increase the risk of food allergies and/ or eczema.  The American Academy of Asthma, Allergy and Immunology (AAAAI) now recommends they be introduced without delay, and not wait up to 1-3 years of age, as advised in the past (5).

  1. Nutrient composition matches breast milk:  We all know that breast milk is the gold standard for feeding infants.  However, if and when it is not possible, and/or a child requires supplementation or is being weaned, Else Nutrition provides a formula with nutrients that match that of breast milk.  The macronutrients (carbohydrates, fat, and protein) and micronutrients (vitamins and minerals) are the same in Else formula-even though Else is a vegan product. Moms and caregivers can be confident that their babies are being nourished while they slowly learn how to eat solids.   
  2. Created and supported by the best team:  These formulas were created by leaders in the infant and toddler nutrition industry.   Their formulation and ingredients have been tested, approved, and supported by pediatricians, gastroenterologists, registered dietitians, and MOMS and DADS!  

References:

  1. https://www.ams.usda.gov/sites/default/files/media/Organic%20Practices%20Factsheet.pdf
  2. https://www.ncbi.nlm.nih.gov/pubmed/29073935
  3. https://www.ncbi.nlm.nih.gov/pubmed/20679230
  4. https://www.mayoclinic.org/diseases-conditions/food-allergy/symptoms-causes/syc-20355095
  5. https://www.jaci-inpractice.org/article/S2213-2198(12)00014-1/fulltext

Source: https://elsenutrition.com/blogs/news/my-search-for-the-healthiest-baby-formula

Toddler Meal Ideas for Picky Eaters – SPONSOR: Else Nutrition $BABY.ca $MAT $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 5:07 PM on Wednesday, April 29th, 2020

SPONSOR: Else Nutrition Holdings Inc. (TSX-V: BABY)The award winning, plant-based nutrition company for small cap investors. The company has a $10,000,000 cash balance for US product launch In Q2 2020 with International agreements in Q3. Learn More

Toddler Meal Ideas for Picky Eaters

By Nicole Silber, RD, CSP, CLC

Children undergo more changes to their growth, development and eating patterns in the years between birth and preschool than any other time in their lives. When babies turn into toddlers, their relatively consistent, predictable eating becomes very inconsistent, paving the way for what many parents would describe as picky eating.

Many parents are concerned with how their toddlers eat (and don’t eat for that matter). What we do know from the Feeding Infants and Toddlers Study (FITS) is that many toddlers and preschoolers eat too much sodium and saturated fat, and not enough key nutrients like potassium, Vitamin D and fiber. But, some of the concerns that I hear from parents regarding their toddlers’ eating stem from a gap in knowing just how much healthy toddlers actually need, and what are normal versus problematic eating behaviors. These concerns usually lead to mealtime tensions, which can perpetuate the picky eating cycle.

Understanding the Needs for Toddler Meals

Understanding what is normal can be very helpful for parents.  Expect toddler meals to be consistently inconsistent – meaning they may skip occasional meals (yes, that means eat a few bites, or nothing), show fluctuating appetites daily based on changing growth needs (meaning when they’re going through a growth spurt they eat much more), and refuse foods one day that they gobbled up the day before. Their willingness to eat at meals may be affected by too much snacking (or grazing), fear of new foods that suddenly develop, or any minor discomfort from teething, a cold or even constipation can impact their willingness to put certain foods, textures and flavors into their mouths. And as a reminder, toddlers are much smaller than adults, so they do not need adult-like portions. For example, healthy toddlers need just 1 cup of veggies each day, so if that’s broken up into 2 meals and a snack that can be just 1/3 of a cup per sitting.  One day they may eat double that, and the next eat none, so look at the average.

Managing expectations can help relieve some parental stress and make way for more positive mealtime environments.  Pushing too hard, trying to convince, sneaking foods, accommodating requests (going to the kitchen and making 3 different dinners), offering bribes to finish the broccoli (yes, we’ve all been there) are all tempting, but can create power struggles that actually intensify the feeding refusals. But, there are some productive things that parents can do to encourage more variety with picky eaters, and the American Academy of Pediatrics (AAP) offers some great tips, like including children in cooking, encouraging family meals, and offering foods repeatedly and in flavorful ways.

Supplementing Toddler Meal Ideas With Something Else

While it’s developmentally normal for toddlers to go through some picky eating phases, some children, and parents alike, struggle to eat balanced, varied meals. And, for children who have any major diet restrictions because of allergies, medical or other lifestyle reasons, they are at higher risk for nutritional deficiencies during times of picky eating. That is when a fortified toddler nutrition drink, like Else, can be a great supplement to their diets. Else complete plant-based toddler meals can help in 2 ways: A more direct benefit is that Else provides these children with an extra boost of calories, fat (particularly unsaturated fat), protein, fiber, omega 3s and many key vitamins and minerals, like iron, potassium, vitamin D needed to support this time of rapid growth. And, Else can provide parents with the reassurance that their little ones are getting the nutrients they need. This reassurance can minimize the stress and pressure placed by parents and felt by kids at mealtimes, which can ultimately encourage more relaxed, varied eating.

Source: https://elsenutrition.com/blogs/news/easy-toddler-meal-ideas-for-picky-eaters

Else Nutrition $BABY.ca Announces Filing of Preliminary Base Shelf Prospectus $MAT $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 12:25 PM on Tuesday, April 28th, 2020
  • Filed its preliminary base shelf prospectus
  • Filing of the Shelf Prospectus, when made final, will allow the Company to qualify the distribution by way of prospectus in British Columbia, Alberta and Ontario of up to C$20,000,000 of common shares, warrants to purchase common shares, units, or any combination thereof, during the 25-month period that the Shelf Prospectus is effective

Not for Distribution in the U.S. or to U.S. Newswire Services

VANCOUVER, BC / April 28, 2020 / Else Nutrition Holdings Inc. (the “Company” or “Else Nutrition” or “Else“) (TSXV:BABY) (OTCQB:BABYF) is pleased to announce that today it has filed its preliminary base shelf prospectus (the “Shelf Prospectus“) with the British Columbia Securities Commission, the Alberta Securities Commission and the Ontario Securities Commission. A copy of the Shelf Prospectus can be found on the Company’s SEDAR profile at www.sedar.com.

The filing of the Shelf Prospectus, when made final, will allow the Company to qualify the distribution by way of prospectus in British Columbia, Alberta and Ontario of up to C$20,000,000 of common shares, warrants to purchase common shares, units, or any combination thereof, during the 25-month period that the Shelf Prospectus is effective. Should the Company decide to offer securities during this period, the specific terms, including the use of proceeds from any offering, will be set forth in a related prospectus supplement to the Shelf Prospectus, which will be filed with the applicable securities commissions.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the qualification under the securities laws of any such jurisdiction.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition GH Ltd. (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc., is a publicly-traded company, listed on the TSX Venture Exchange under the trading symbol “BABY” and is quoted on the US OTC Markets QB board under the trading symbol “BABYF”. The Company’s Executive and Advisory Board includes leaders hailing from Abbott Nutrition, Mead Johnson, Boston Children’s Hospital, ESPHGAN (European Society for Pediatric Gastroenterology, Hepatology and Nutrition), Plum Organics, Tel Aviv University’s Sackler Faculty of Medicine, and Gastroenterology & Nutrition Institute of RAMBAM Medical Center.

For further information, please contact:

Ms. Hamutal Yitzhak, CEO of Else Nutrition
Email: [email protected]

Mr. Sokhie Puar, Director of Else Nutrition
Telephone: 604-603-7787
Email: [email protected]

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

The securities described herein have not been registered under the U.S. Securities Act or any state securities laws, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements under the U.S. Securities Act and any applicable state securities laws.

Certain information contained herein constitutes “forward-looking information” under Canadian securities legislation. Forward-looking information includes, but is not limited to, statements with respect to the Shelf Prospectus. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “will” or variations of such words and phrases or statements that certain actions, events or results “will” occur. Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made and they are subject to known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from those expressed or implied by such forward-looking statements or forward-looking information, including: the receipt of all necessary regulatory approvals, use of proceeds from the financing, capital expenditures and other costs, and financing and additional capital requirements. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward looking information. The Company will not update any forward-looking statements or forward-looking information that is incorporated by reference herein, except as required by applicable securities laws.

VIDEO: Else Nutrition $BABY.ca Has $10M In Cash And A Billion Dollar Shareholder To Launch Plant Based Toddler Foods Around The World $MAT $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 6:04 PM on Monday, April 27th, 2020

When the subsidiary of a Billion Dollar, Nutrition Focused company buys 11.5% of your stock, agrees to a voluntary 12-month lock up and holds anti-dilution rights to maintain it’s ownership percentage by buying a proportionate number of shares in any future financing, it is safe to assume you have a strategic investor who believes in the future of your company.    When that same strategic investor wants to then help your company expand into large international markets, it is safe to assume your plant based food capabilities are amongst the most respected in the world.   This is just a glimpse into the strength of Else Nutrition (BABY:TSXV) (BABYF:OTCQB), an Israeli based, award winning plant based food nutrition company that is giving small cap investors an opportunity to participate in the global paradigm shift towards plant-based, clean label foods.   BUT THERE IS MORE

  • Else has a $10,000,000 war chest for a US product launch in Q2 and to start signing international agreements in Q3. 
  • These global plans are supported by patents in 22 countries, with another 44 countries pending.  
  • Else developed the world’s first 100% plant based, non-dairy, non-soy baby formula

Given all of these achievements, it should come as no surprise that Else Nutrition is made up of Executives & Advisors from globally renowned companies and institutions.   If you believe in the future of plant-based, clean label foods or want to discover its possibilities, then watch our first ever interview with Hamutal Yitzhak, the CEO and Co-Founder of Else Nutrition who will tell you about both the Company’s origins and future path.

CLIENT FEATURE: Else Nutrition Holdings $BABY.ca An Award Winning, Plant-Based Nutrition Company For Small Cap Investors $MAT $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 6:08 PM on Thursday, April 23rd, 2020

Highlights

  • $CAD 10 million cash and runway for well over a year;
  • Backed By A Billion Dollar Global Nutrition Company;
  • MOU For International Distribution Of Products
  • US Product Launch Planned For Q2-2020;
  • “Best Health” Award At Global Food Innovation Summit In Milan;
  • Awarded Patents In 22 Countries, 44 Countries Pending;
  • Executives & Advisors From Globally Renowned Companies & Institutions

Why Else Nutrition?

  • Gives Small Cap Investors An Opportunity To Participate In Global Paradigm Shift Towards Plant-Based, Clean Label Foods For Toddlers & Children.
  • Entering Commercialization Stage After 7 Years R&D
  • Launching 1st Commercial Product Into US Market Q2
  • 100% Plant-Based, Organic Toddler Nutrition Product 
  • Market Research Survey Finds Over 60% Positive Purchase Intent For Else Product
  • Fills A Market Gap In Plant-Based Toddler Nutrition (12-36 months)
  • Subsidiary Of Billion Dollar Hong Kong Listed Conglomerate (H&H) Owns Approx 11.15% Of BABY
  • H&H Shares Have Voluntary 12-Month Hold
  • H&H Right To Maintain 11.15% Ownership Through Future Financings
  • Patented World’s First 100% Plant Based, Non-Dairy, Non-Soy Baby Formula

Here’s What The Experts Say

“Finally a high quality, nutritionally-dense, tasty, plant-based alternative that is low in sugar.  Else is filling a much needed gap, and providing an alternative for those looking to avoid dairy or soy, and a viable option for intolerances and other diet considerations.”

Nicole Silber, RD, CSP, CLC

Dairy-free, soy-free, plant-based nutrition for babies and toddlers

Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan.

The Product

Else Plant-Based Toddler Nutrition

Dairy-free | Soy-free | Corn Syrup-free | Gluten-free

Made with real, whole foods, it meets the highest standard for nutrition

  • Endorsed by leading pediatricians and nutritionists 
  • Ingredients, vitamins & minerals to support your child’s growth and development
  • 92% whole plant ingredients (almonds, tapioca, buckwheat) 
  • Organic & non-GMO
  • Made by the cleanest process possible
  • Globally patented 

Else Nutrition Holdings is an advertising client of AGORA Internet Relations Corp.

AGORACOM Welcomes Else Nutrition $BABY.ca – The Award Winning, Plant-Based Nutrition Company For Small Cap Investors; $10,000,000 Cash Balance For US product Launch In Q2 2020, Int’l Agreements Q3

Posted by AGORACOM-JC at 8:30 AM on Monday, April 20th, 2020

Highlights

  • $CAD 10 million cash and runway for well over a year;
  • Backed By A Billion Dollar Global Nutrition Company;
  • MOU For International Distribution Of Products
  • US Product Launch Planned For Q2-2020;
  • “Best Health” Award At Global Food Innovation Summit In Milan;
  • Awarded Patents In 22 Countries, 44 Countries Pending;
  • Executives & Advisors From Globally Renowned Companies & Institutions

Why Else Nutrition?

  • Gives Small Cap Investors An Opportunity To Participate In Global Paradigm Shift Towards Plant-Based, Clean Label Foods For Toddlers & Children.
  • Entering Commercialization Stage After 7 Years R&D
  • Launching 1st Commercial Product Into US Market Q2
  • 100% Plant-Based, Organic Toddler Nutrition Product 
  • Market Research Survey Finds Over 60% Positive Purchase Intent For Else Product
  • Fills A Market Gap In Plant-Based Toddler Nutrition (12-36 months)
  • Subsidiary Of Billion Dollar Hong Kong Listed Conglomerate (H&H) Owns Approx 11.15% Of BABY
  • H&H Shares Have Voluntary 12-Month Hold
  • H&H Right To Maintain 11.15% Ownership Through Future Financings
  • Patented World’s First 100% Plant Based, Non-Dairy, Non-Soy Baby Formula

Here’s What The Experts Say

“Finally a high quality, nutritionally-dense, tasty, plant-based alternative that is low in sugar.  Else is filling a much needed gap, and providing an alternative for those looking to avoid dairy or soy, and a viable option for intolerances and other diet considerations.”

Nicole Silber, RD, CSP, CLC

Dairy-free, soy-free, plant-based nutrition for babies and toddlers

Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan.

The Product

Else Plant-Based Toddler Nutrition

Dairy-free | Soy-free | Corn Syrup-free | Gluten-free

baby-100

Made with real, whole foods, it meets the highest standard for nutrition

  • Endorsed by leading pediatricians and nutritionists 
  • Ingredients, vitamins & minerals to support your child’s growth and development
  • 92% whole plant ingredients (almonds, tapioca, buckwheat) 
  • Organic & non-GMO
  • Made by the cleanest process possible
  • Globally patented 
nutrition
BABY-screen1

LEARN MORE!

Hub On AGORACOM / Corporate Profile

Else Nutrition $BABY.ca Announces Expansion of Intellectual Property Portfolio to India and Canada

Posted by AGORACOM-JC at 8:24 AM on Monday, April 20th, 2020
  • Announced that the Company has expanded its intellectual property (IP) portfolio to India and Canada
  • Received a formal grant from the Indian Patent office for its patent application 640/CHENP/2015, and a notice of allowance from the Canadian Intellectual Property Office for its patent application 2898980, for its proprietary, clean, plant-based formulation for infant and toddler populations

VANCOUVER, BRITISH COLUMBIA / April 20, 2020 / ELSE NUTRITION HOLDINGS INC. (TSXV:BABY)(OTCQB:BABYF) (“Else” or the “Company“), a developer of novel plant-based infant and toddler nutrition, is pleased to announce that the Company has expanded its intellectual property (IP) portfolio to India and Canada.

The Company has received a formal grant from the Indian Patent office for its patent application 640/CHENP/2015, and a notice of allowance from the Canadian Intellectual Property Office for its patent application 2898980, for its proprietary, clean, plant-based formulation for infant and toddler populations.

“These are highly encouraging developments in key growth markets as we aim to extend our global reach and impact,” stated Ms. Hamutal Yitzhak, Else Nutrition CEO & Co-Founder. She added, “We continue to hear from parents across all geographies that our clean, plant-based infant and toddler formulations can provide a viable alternative for parents seeking an alternative to formulas which contain cow’s milk protein or soy protein.”

Additionally, since March 11, 2020, the Company has engaged AGORACOM for investor awareness, marketing and branding services (the “Advertising Services“). As consideration for the Advertising Services, Else will issue an aggregate of $60,000 plus applicable taxes in the form of common shares of Else (the “Shares“). The Shares are payable in five equal installments during a period from April 2020 until March 2021 for a total term of one-year, as further provided in the online marketing agreement between the Company and AGORACOM. The number of Shares to be issued each time an installment is due will be determined by using the closing price of the Shares of Else on the last trading day following each period for which the Advertising Services were provided. In accordance with Policy 4.3 – Shares for Debt, each Share issuance installment is subject to approval from the TSX Venture Exchange. The number and amount of each issuance will be disclosed by way of a press release when such Shares are issued.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc, is a publicly-traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QB board under the trading symbol BABYF. Else’s Executive and Advisory Board includes leaders hailing from Abbott Nutrition, Mead Johnson, Boston Children’s Hospital, ESPHGAN (European Society for Pediatric Gastroenterology, Hepatology and Nutrition). Plum Organics, Tel Aviv University’s Sackler Faculty of Medicine, and Gastroenterology & Nutrition Institute of RAMBAM Medical Center.

For more information, contact:

Ms. Hamutal Yitzhak, CEO, Co-Founder & Director
Else Nutrition Holdings Inc.
E: [email protected]

Mr. Sokhie Puar, Director of Else Nutrition Holdings Inc.
Telephone: 604-603-7787
Email: [email protected]

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that, to the extent they are not recitations of historical fact, constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will”, “to be”, “intend” or similar expressions. Forward-looking statements in this press release include, but are not limited to, statements with respect to the Company’s expected go-to-market strategy (including marketing, proposed markets, sales, customer growth and market position) and the share issuances made to AGORACOM.

Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of historical trends, current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct.

Forward-looking statements made in this press release assume, among others, the successful completion of Else’s proposed scale-up for its products, and such statements are intended to apply only to the infant formula market for ages 12 months and above, and having all necessary regulatory approval as required by each target market.

Numerous risks and uncertainties could cause the Company’s actual results to differ materially from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements, including, but not limited to: consumer demand for the Company’s products, whether the Company’s current and future products achieve commercialization, uncertainty regarding material changes in laws and regulations and the Company’s ability to expand into global markets.

In addition, the Company is subject to risks and uncertainties caused by the COVID-19 pandemic which has resulted in governments worldwide enacting emergency measures to combat the spread of the virus including travel bans, self-imposed quarantine periods and social distancing. The outbreak of COVID-19 can impact our operations in a number of ways including quarantined employees, travel restrictions, temporary closure of our office, as well as interruptions to our manufacturing and supply chains.

The foregoing list of factors is not exhaustive, and other risks and uncertainties not presently known, or believed to be material, to management and other factors that could affect the operations or financial results of the Company are set out in the Company’s Filing Statement dated May 14, 2019 under the heading “Risk Factors” and may be accessed through the SEDAR website (www.sedar.com).

Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

SOURCE: ELSE Nutrition Holdings